CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 115 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,003 | -99.7% | 160,000 | +60.0% | 1.20% | +206.4% |
| Q3 2022 | $350,000 | -43.5% | 100,000 | -52.4% | 0.39% | -40.8% |
| Q2 2022 | $620,000 | +32.8% | 210,000 | +40.0% | 0.66% | +68.4% |
| Q1 2022 | $467,000 | -7.9% | 150,000 | 0.0% | 0.39% | +2.3% |
| Q4 2021 | $507,000 | -7.5% | 150,000 | 0.0% | 0.38% | -6.4% |
| Q3 2021 | $548,000 | -16.2% | 150,000 | 0.0% | 0.41% | -13.5% |
| Q2 2021 | $654,000 | -4.0% | 150,000 | 0.0% | 0.47% | -6.5% |
| Q1 2021 | $681,000 | – | 150,000 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,629,464 | $14,208,926 | 10.61% |
| Lynx1 Capital Management LP | 1,369,927 | $11,945,763 | 9.96% |
| Versant Venture Management, LLC | 543,753 | $4,741,526 | 9.88% |
| Foresite Capital Management IV, LLC | 1,787,094 | $15,583,460 | 8.09% |
| Octagon Capital Advisors LP | 4,570,918 | $39,858,405 | 5.74% |
| ACUTA CAPITAL PARTNERS, LLC | 878,500 | $7,660,520 | 5.64% |
| TCG Crossover Management, LLC | 3,048,257 | $26,580,801 | 5.18% |
| Affinity Asset Advisors, LLC | 1,083,118 | $9,444,789 | 3.12% |
| Altium Capital Management LP | 620,000 | $5,406,400 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 2,500,000 | $21,800 | 2.72% |